The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Genetic Control of Isoniazid Metabolism in Man
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Metabolism of isoniazid in man as related to the occurrence of peripheral neuritis.
Hughes, H. B., Biehl, J., Jones, A., & Schmidt, L. H. (1954) · PubMed · doi:10.1164/art.1954.70.2.266 · Cited by 225
Tuberculosis Chemotherapy with Hydrazine Derivatives of Isonicotinic Acid
Selikoff, I. J., & Robitzek, E. H. (1952) · Diseases of the Chest · doi:10.1378/chest.21.4.385 · Cited by 94
Robitzek, E. H., SELIKOFF, I. J., & Ornstein, G. G. (1952) · PubMed · Cited by 63
Imperfection: Biochemical Phobias and Metabolic Ambivalence
Drabkin, D. L. (1959) · Perspectives in biology and medicine · doi:10.1353/pbm.1959.0037 · Cited by 39
Cited by
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
Evans, W. E., & Relling, M. V. (1999) · Science · doi:10.1126/science.286.5439.487 · Cited by 2,475
Pharmacogenomics — Drug Disposition, Drug Targets, and Side Effects
Evans, W. E., & McLeod, H. L. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020526 · Cited by 1,769
Weinshilboum, R. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020021 · Cited by 1,031
Development of a Large-Scale De-Identified DNA Biobank to Enable Personalized Medicine
Roden, D., Pulley, J., Basford, M., Bernard, G., Clayton, E., Balser, Jr., & Masys, D. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.89 · Cited by 983
Subgroup analysis in randomised controlled trials: importance, indications, and interpretation
Rothwell, P. M. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17709-5 · Cited by 942
Pharmacogenomics in the clinic
Relling, M. V., & Evans, W. E. (2015) · Nature · doi:10.1038/nature15817 · Cited by 904
Bertz, R. J., & Granneman, G. R. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199732030-00004 · Cited by 755
Role of Pharmacokinetics and Metabolism in Drug Discovery and Development
Lin, J. H., & Lu, A. Y. H. (1997) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01340-1 · Cited by 708
Pediatric acute lymphoblastic leukemia
Inaba, H., & Mullighan, C. G. (2020) · Haematologica · doi:10.3324/haematol.2020.247031 · Cited by 696
Pharmacogenetics, Pharmacogenomics, and Individualized Medicine
Ma, Q., & Lu, A. Y. H. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003533 · Cited by 464
BLUM, M., GRANT, D. M., McBRIDE, W., HEIM, M., & MEYER, U. A. (1990) · DNA and Cell Biology · doi:10.1089/dna.1990.9.193 · Cited by 435
Pharmacogenetics – five decades of therapeutic lessons from genetic diversity
Meyer, U. A. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1428 · Cited by 420
Pharmacogenomics: The Inherited Basis for Interindividual Differences in Drug Response
Evans, W. E., & Johnson, J. A. (2001) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.2.1.9 · Cited by 415
Pharmacogenetics, Drug-Metabolizing Enzymes, and Clinical Practice
Gardiner, S. J., & Begg, E. J. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.6 · Cited by 406
Woosley, R. L., Drayer, D. E., Reidenberg, M. M., Nies, A. S., Carr, K., & Oates, J. A. (1978) · New England Journal of Medicine · doi:10.1056/nejm197805252982101 · Cited by 389
Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine
Ahmed, S., Zhou, Z., Zhou, J., & Chen, S.-Q. (2016) · Genomics, Proteomics & Bioinformatics · doi:10.1016/j.gpb.2016.03.008 · Cited by 371
Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populations
Alv�n, G., Bechtel, P., Iselius, L., & Gundert-Remy, U. (1990) · European Journal of Clinical Pharmacology · doi:10.1007/bf00316090 · Cited by 361
Enzymatic activation of chemicals to toxic metabolites
Guengerich, F. P., Liebler, D. C., & Reed, D. L. (1985) · CRC Critical Reviews in Toxicology · doi:10.3109/10408448509037460 · Cited by 334
Pharmacogenomics: bench to bedside
Weinshilboum, R., & Wang, L. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1497 · Cited by 320
Acetylator genotype and arylamine-induced carcinogenesis
Hein, D. W. (1988) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(88)90004-2 · Cited by 317
Precision Medicine: Disease Subtyping and Tailored Treatment
Wang, R. C., & Wang, Z. (2023) · Cancers · doi:10.3390/cancers15153837 · Cited by 315
Wormhoudt, L. W., Commandeur, J. N. M., & Vermeulen, N. P. E. (1999) · Critical Reviews in Toxicology · doi:10.1080/10408449991349186 · Cited by 302
Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis
Unissa, A. N., Subbian, S., Hanna, L. E., & Selvakumar, N. (2016) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2016.09.004 · Cited by 300
Monoamine Oxidase Inhibitors: A Review of Antidepressant Effectiveness
Quitkin, F. (1979) · Archives of General Psychiatry · doi:10.1001/archpsyc.1979.01780070027003 · Cited by 300
The genetic basis of variability in drug responses
Roden, D. M., & George Jr, A. L. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd705 · Cited by 292
Pharmacogenomics: Challenges and Opportunities
Roden, D. M., Altman, R. B., Benowitz, N. L., Flockhart, D. A., Giacomini, K. M., Johnson, J. A., Krauss, R. M., McLeod, H. L., Ratain, M. J., Relling, M. V., et al. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-10-200611210-00007 · Cited by 282
Pharmacogenetics-based tuberculosis therapy research group, Azuma, J., Ohno, M., Kubota, R., Yokota, S., Nagai, T., Tsuyuguchi, K., Okuda, Y., Takashima, T., Kamimura, S., et al. (2013) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-012-1429-9 · Cited by 278
Pharmacogenomics: The promise of personalized medicine
Mancinelli, L., Cronin, M., & Sadée, W. (2000) · AAPS PharmSci · doi:10.1208/ps020104 · Cited by 267
Review article: drug hepatotoxicity
CHANG, C. Y., & SCHIANO, T. D. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03307.x · Cited by 264
Isoniazid metabolism and hepatotoxicity
Wang, P., Pradhan, K., Zhong, X.-B., & Ma, X. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.07.014 · Cited by 257
Hypertensive Interactions Between Monoamine Oxidase Inhibitors and Foodstuffs
Blackwell, B., Marley, E., Price, J., & Taylor, D. (1967) · British Journal of Psychiatry · doi:10.1192/bjp.113.497.349 · Cited by 256
Identification and validation of N-acetyltransferase 2 as an insulin sensitivity gene
Knowles, J. W., Xie, W., Zhang, Z., Chennemsetty, I., Assimes, T. L., Paananen, J., Hansson, O., Pankow, J., Goodarzi, M. O., Carcamo-Orive, I., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci74692 · Cited by 141
Hein, D. W., & Doll, M. A. (2012) · Pharmacogenomics · doi:10.2217/pgs.11.122 · Cited by 121
(2011) · Europe PMC (PubMed Central) · Cited by 55
Salazar-González, R. A., Turiján-Espinoza, E., Hein, D. W., Milán-Segovia, R. C., Uresti-Rivera, E. E., & Portales-Pérez, D. P. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.08.034 · Cited by 20
“Differences in response to the anti-tuberculosis therapy between patients [39,40] led to the description of rapid and slow acetylation phenotypes.”
Metadata
- Authors
- Evans, D. A. P., Manley, K. A., & McKusick, V. A.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1960-08-13
- Volume
- 2
- Issue
- 5197
- Pages
- 485-491
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2093714545
- Cited by
- 784
- References
- 4
- FWCI
- 23.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.